Organizers claimed that nearly 2 million Hong Kong protesters took to the streets Sunday in a rally to demand the city's top official resign a day after she suspended — but...China Politicsread more
Heavy rains caused unprecedented delays in planting this year and contributed to record floods across the central United States.Agricultureread more
Stocks in Asia traded mixed on Monday as investors await a U.S. Federal Reserve meeting set to happen later in the week stateside.Asia Marketsread more
Although Cook did not mention companies by name, his commencement speech in Silicon Valley's backyard mentioned data breaches, privacy violations, and even made reference to...Technologyread more
In the survey, 66% of Democratic primary voters say they'd be enthusiastic or comfortable about Biden as their nominee to take on President Trump in the 2020 election. Just...Politicsread more
U.S. ambassador to Israel David Friedman called the gesture a "birthday present" to Trump, who turned 73 on Friday.Politicsread more
The outlook for Germany's economy and political stability are more uncertain than ever, writes Michael Ivanovitch.World Economyread more
Hong Kong democracy activist Joshua Wong walked free from prison on Monday after serving nearly five weeks for contempt of court, pledging to join a mass protest movement...China Politicsread more
The agreement, which is on the framework for the plan of adjustment, provide for more than a 60% average haircut for all $35 billion, a 36% haircut on pre-2012 general...Bondsread more
Target's registers were down on Saturday for several hours preventing customers from checking out.Retailread more
The newspaper wrote that Goldman's executive are hoping CEO David Solomon's changes to a firm that historically thrived in investment banking and trading will boost its...US Marketsread more
Called the 'Viagra for women,' female libido-boosting drug, Addyi, hasn't had much of a hot start on the market.
After just two weeks of availability, the online health and medicine publication STAT reported that only 80 prescriptions have been filled for the pill through the end of October.
The drug, which treats sexual dysfunction in women, was the first of its kind to be approved by the Federal Drug Administration after being rejected twice because it showed only modest benefits. Addyi was manufactured by Sprout Pharmaceuticals—a company recently acquired by Valeant Pharmaceuticals.
According to the STAT report, Addyi's low prescription count could be attributed to a key limitation of the drug. While the drug must be taken every day to be effective, it can never be mixed with alcohol.
Read STAT's full report here.
Clarification: This story has been updated to reflect that STAT is an online health and medicine publication. STAT is a content partner of the Boston Globe.